Karen Lighting Jones, Head of Future Place at Roche. Back in 2016, Dame Sally Davies concluded her Chief Medical Officer annual report by saying “Genomics is not tomorrow, it’s here today. I believe genomic services should be available to more patients, whilst being a cost-effective service in the NHS”.
In a recent study in mice, researchers found that engineered immune cells were able to shrink tumours and prevent the […]
Since the emergence of the novel coronavirus SARS-CoV-2 in December 2019, over 115 million cases have been reported worldwide. Whole […]
The first cancer genome paper was published in 2008, and in just 13 years the power of sequencing and analytics […]
In a new study, researchers analysed gene expression patterns in fresh brain tissue, revealing that some ‘zombie’ cells increase their […]
A preclinical study has provided experimental evidence that supports the use of antisense oligonucleotides as a strategy to treat MECP2 […]
Pharma R&D productivity is decreasing. The COVID-19 pandemic has meant most pharma companies have rapidly turned towards digital strategies. The […]
Study shows how one specific combination therapy may provide measurable benefits to patients with mitochondrial respiratory chain disorders. Mitochondrial disorders […]
Another round-up of the latest genomics news and research from the past week – enjoy! Top stories from the past […]
Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]
